BSE filing, NSE: CENTUM. Summary written from the filing by ALFA Finder's alert engine.
Centum Electronics Ltd: key numbers
- Share price
- ₹4,265.30
- Market cap
- ₹6,296 Cr
- Revenue (annual)
- ₹962.7 Cr
- Net profit (annual)
- ₹-46.65 Cr
- P/E (TTM)
- 126.9×Sector 45.0×
- Promoter holding
- 46.81%-0.01% QoQ
- FII holding
- 3.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Centum Electronics Ltd
All →Centum Electronics Q2 FY27 Results: Net Profit ₹22.9 Cr, Up 458.5% YoY
Centum Electronics Ltd reported revenue from operations of ₹312.1 Cr (+58.7% YoY) and net profit of ₹22.9 Cr (+458.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹22.9 Cr · +458.5% YoY
Centum Electronics Board Meeting Date
Centum Electronics scheduled its Board meeting for November 4, 2026, to approve Q2/H1 FY27 results. An earnings call follows on November 5.
Centum Electronics Other Announcement
Centum Electronics Ltd has filed the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Centum Electronics Investor Presentation: Key Takeaways
Centum Electronics delivered Q1-FY27 standalone revenue of INR 2,048 Mn with 11.28% EBITDA margin, driven by its dual EMS-BTS model.
Centum Electronics Credit Rating
CARE Ratings upgraded Centum Electronics' bank facilities to CARE BBB+ Stable/CARE A2. This revision reflects the company's exit from loss-making overseas subsidiaries and growing order book.
Centum Electronics Capital Structure Change
Designated person Vinod Srinivasrao Chippalkatti sold 309 equity shares of Centum Electronics Ltd via market sale, valued at Rs. 13.43 Lakhs.
- Value
- ₹0.13 Cr
Other other announcement announcements
All →Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.
Gujarat Kidney and Super Speciality Other Announcement
Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.
PDS Other Announcement
PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.